Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index

被引:35
|
作者
Cohen, Ricardo [1 ]
Caravatto, Pedro Paulo
Correa, Jose Luis
Noujaim, Patricia
Petry, Tarissa Zanata
Salles, Joao Eduardo
Schiavon, Carlos Aurelio
机构
[1] Hosp Alemao Oswaldo Cruz, Ctr Surg Treatment Morbid & Metab Disorders, Dept Surg, BR-01411000 Sao Paulo, Brazil
关键词
Bariatric surgery; Glucose metabolism; Insulin sensitivity; GASTRIC BYPASS; WEIGHT-LOSS; INSULIN-RESISTANCE; TYPE-2; OBESITY; GLUCOSE; DIET;
D O I
10.1016/j.soard.2012.01.017
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Bariatric surgery frequently results in the resolution of type 2 diabetes mellitus (T2DM). One of the many factors that could explain such findings is the duodenal exclusion of the alimentary tract. To test this hypothesis, a surgical model that induces glycemic control without significant weight loss would be ideal. In the present study, we evaluated the early metabolic changes that occur in overweight diabetic patients after laparoscopic duodenal-jejunal bypass (DJB) and determined the factors associated with success in T2DM resolution. The setting was a private practice. Methods: A total of 35 patients (20 men and 15 women) were included in the present study. The mean preoperative body mass index was 28.4 +/- 2.9 kg/m(2). DJB was performed in all patients, and the anthropometric data and blood samples were collected at baseline (preoperatively) and 3, 6, 9, and 12 months after surgery. Success was defined when patients reached a glycated hemoglobin level of <7% without diabetic medication. Results: T2DM remission was observed in 14 (40%) of 35 patients. No differences in the homeostasis model assessment insulin resistance index levels and patient weight were observed before and 12 months after DJB surgery. Gender, duration of T2DM, previous use of insulin, preoperative homeostasis model assessment insulin resistance index, and C-peptide levels were not significant predictive factors of success or nonsuccess. The only factor that significantly predicted postoperative positive outcomes was a waist circumference reduction of >= 7% compared with baseline within the first 6 months after surgery. Conclusion: DJB improves glycemic control; however, it does not increase insulin sensitivity in overweight diabetic patients. These changes were observed without significant weight loss. (Surg Obes Relat Dis 2012;8:375-380.) (c) 2012 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 50 条
  • [11] Duodenal-jejunal bypass for the treatment of type 2 diabetes in Chinese patients with an average body mass index &lt;24 kg/m2
    Jiang, Feizhao
    Zhu, Hengliang
    Zheng, Xiaofeng
    Tu, Jinfu
    Zhang, Weijian
    Xie, Xuemeng
    SURGERY FOR OBESITY AND RELATED DISEASES, 2014, 10 (04) : 641 - 646
  • [12] Duodenal-Jejunal Bypass Surgery Suppresses Hepatic De Novo Lipogenesis and Alleviates Liver Fat Accumulation in a Diabetic Rat Model
    Han, Haifeng
    Hu, Chunxiao
    Wang, Lei
    Zhang, Guangyong
    Liu, Shaozhuang
    Li, Feng
    Sun, Dong
    Hu, Sanyuan
    OBESITY SURGERY, 2014, 24 (12) : 2152 - 2160
  • [13] Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass
    Han, Haifeng
    Wang, Lei
    Du, Hao
    Jiang, Jianjun
    Hu, Chunxiao
    Zhang, Guangyong
    Liu, Shaozhuang
    Zhang, Xiang
    Liu, Teng
    Hu, Sanyuan
    OBESITY SURGERY, 2015, 25 (10) : 1802 - 1809
  • [14] Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery
    Jie Chai
    Guangyong Zhang
    Shaozhuang Liu
    Chunxiao Hu
    Haifeng Han
    Sanyuan Hu
    Zongli Zhang
    Obesity Surgery, 2016, 26 : 261 - 268
  • [15] Effects of Duodenal-Jejunal Bypass Liner (EndoBarrierA®) on Gastric Emptying in Obese and Type 2 Diabetic Patients
    Hourneaux de Moura, Eduardo Guimaraes
    Lopes, Guilherme Sauniti
    Martins, Bruno da Costa
    Bonotto Orso, Ivan Roberto
    Novaes Coutinho, Artur Martins
    de Oliveira, Suzana Lopes
    Sakai, Paulo
    Galvao-Neto, Manoel dos Passos
    Santo, Marco Aurelio
    Sapienza, Marcelo Tatit
    Cecconello, Ivan
    Buchpiguel, Carlos Alberto
    OBESITY SURGERY, 2015, 25 (09) : 1618 - 1625
  • [16] Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients
    Eduardo Guimarães Hourneaux de Moura
    Guilherme Sauniti Lopes
    Bruno da Costa Martins
    Ivan Roberto Bonotto Orso
    Artur Martins Novaes Coutinho
    Suzana Lopes de Oliveira
    Paulo Sakai
    Manoel dos Passos Galvão-Neto
    Marco Aurélio Santo
    Marcelo Tatit Sapienza
    Ivan Cecconello
    Carlos Alberto Buchpiguel
    Obesity Surgery, 2015, 25 : 1618 - 1625
  • [17] Duodenal-jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats
    Yang, Guangwei
    Liu, Zitian
    Dong, Shuohui
    Zhao, Xiang
    Ge, Zheng
    Cheng, Zhiqiang
    Zhang, Xiang
    Wang, Kexin
    JOURNAL OF DIABETES, 2024, 16 (07)
  • [18] Glycemic Control in Diabetic Patients after Bariatric Surgery
    Maria de Fátima Haueisen Sander Diniz
    Marco Túlio Costa Diniz
    Soraya Rodrigues Almeida Sanches
    Patrícia Paz Cabral de Almeida Salgado
    Maristane Mendes Andrade Valadão
    Cláudia Patrícia Freitas
    David José Vieira
    Obesity Surgery, 2004, 14 : 1051 - 1055
  • [19] Glycemic control in diabetic patients after bariatric surgery
    Diniz, MDFHS
    Diniz, MTC
    Sanches, SRA
    Salgado, PPCDA
    Valadao, MMA
    Freitas, CP
    Vieira, DJ
    OBESITY SURGERY, 2004, 14 (08) : 1051 - 1055
  • [20] Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes
    Jirapinyo, Pichamol
    Haas, Andrea V.
    Thompson, Christopher C.
    DIABETES CARE, 2018, 41 (05) : 1106 - 1115